Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans.
Characterization of the absorption, metabolism, excretion, and mass balance of gefapixant in humans.
Journal: Pharmacology research & perspectives
Published: January 10, 2022
Pharmacokinetic and Safety Profile of the Novel HIV Nonnucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV.
Journal: Antimicrobial agents and chemotherapy
Published: September 13, 2021
Fluoride Pharmacokinetics in Urine and Plasma Following Multiple Doses of MK-8507, an Investigational, Oral, Once-Weekly Nonnucleoside Reverse Transcriptase Inhibitor.
Journal: Journal of clinical pharmacology
Published: August 26, 2021
A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV.
Journal: Clinical drug investigation
Published: May 26, 2021
A Phase 1 Trial to Evaluate the Relationship Between Fluoride Intake and Urinary Fluoride Excretion in Healthy Participants.
Journal: Journal of clinical pharmacology
Published: May 05, 2021
Assessment of Pharmacokinetic Interaction Between Letermovir and Fluconazole in Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: January 29, 2020
A large multicentre, randomized, double-blind, cross-over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US- and EU-reference biologics.
Journal: British journal of clinical pharmacology
Published: August 13, 2019
First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: July 09, 2019
Metabolism, Excretion, and Pharmacokinetics of [14 C]-Cefiderocol (S-649266), a Siderophore Cephalosporin, in Healthy Subjects Following Intravenous Administration.
Journal: Journal of clinical pharmacology
Published: October 31, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026